NCT04579757 2025-05-08Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid TumorsHutchmedPhase 1/2 Terminated87 enrolled 29 charts
NCT05500508 2024-12-24Oral AMXT 1501 Dicaprate in Combination With IV DFMOAminex Therapeutics, Inc.Phase 1/2 Terminated15 enrolled
NCT04077372 2023-01-27Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal CancersStanford UniversityPhase NA Terminated12 enrolled